Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Crook

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
QJM : Monthly Journal of the Association of Physicians|January 11, 2000
Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemiasA S Wierzbicki, P J Lumb, Y Semra, et al.
Annals of Clinical Biochemistry|February 5, 2003
Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucoseM A Crook, L Goldsmith, P Ameerally, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2003
Serum sialic acid, a reputed cardiovascular risk factor, is related to serum leptin concentrations in FijiansM A Crook, J Miell, P Ameerally, et al.
European Journal of Clinical Investigation|October 13, 2000
Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessationM A Crook, D A Scott, J A Stapleton, et al.
International Journal of Clinical Practice|May 14, 2011
Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort studyA S Wierzbicki, S Pendleton, Z McMahon, et al.
Diabetes Care|August 1, 1995
Serum sialic acid concentration and coronary heart disease in NIDDMJ C Pickup, M B Mattock, M A Crook, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1996
Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitusJ K Powrie, G F Watts, M A Crook, et al.
Clinical Endocrinology|September 1, 1999
Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled studyE R Christ, M H Cummings, P J Lumb, et al.
Diabetes Care|February 24, 2001
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications StudyM A Crook, J C Pickup, P J Lumb, et al.
International Journal of Clinical Practice|March 18, 2008
Insulin resistance phenotypes and coronary artery disease in a native Pakistani cohortA S Wierzbicki, S Nishtar, P J Lumb, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
QJM : Monthly Journal of the Association of Physicians|January 11, 2000
Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemiasA S Wierzbicki, P J Lumb, Y Semra, et al.
Annals of Clinical Biochemistry|February 5, 2003
Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucoseM A Crook, L Goldsmith, P Ameerally, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2003
Serum sialic acid, a reputed cardiovascular risk factor, is related to serum leptin concentrations in FijiansM A Crook, J Miell, P Ameerally, et al.
European Journal of Clinical Investigation|October 13, 2000
Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessationM A Crook, D A Scott, J A Stapleton, et al.
International Journal of Clinical Practice|May 14, 2011
Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort studyA S Wierzbicki, S Pendleton, Z McMahon, et al.
Diabetes Care|August 1, 1995
Serum sialic acid concentration and coronary heart disease in NIDDMJ C Pickup, M B Mattock, M A Crook, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1996
Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitusJ K Powrie, G F Watts, M A Crook, et al.
Clinical Endocrinology|September 1, 1999
Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled studyE R Christ, M H Cummings, P J Lumb, et al.
Diabetes Care|February 24, 2001
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications StudyM A Crook, J C Pickup, P J Lumb, et al.
International Journal of Clinical Practice|March 18, 2008
Insulin resistance phenotypes and coronary artery disease in a native Pakistani cohortA S Wierzbicki, S Nishtar, P J Lumb, et al.
Pageof 10